Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
Lilly's Mounjaro rivals Trulicity in cardiovascular risk reduction
Mounjaro rivals its GLP-1 predecessor, Trulicity, in reducing cardiovascular events in type 2 diabetes and outperforms in A1C reduction, weight loss and cardiovascular biomarkers.
-
Monarez becomes first CDC Director requiring Senate approval
Susan Monarez is the first CDC director subject to Senate approval and the first non‑physician in 70 years to lead the agency.
-
Mail-order, retail pharmacies outpace chains in patient satisfaction
Driven by better digital access and satisfaction scores, patients are favoring mail-order, supermarket and mass merchandiser pharmacies over chain drugstores.
-
FDA regulatory gaps fuel unsafe compounded GLP-1 drugs
Regulatory loopholes let compounders mass-produce untested GLP-1 drug knock-offs under the guise of personalization, prompting urgent FDA action to ensure patient safety.
-
HHS approves thimerosal removal from flu vaccines
HHS Secretary Robert F. Kennedy Jr. backs the removal of thimerosal from U.S. flu vaccines following a CDC advisory committee vote, impacting less than 5% of shots.
-
FDA Commissioner names George Tidmarsh as new CDER director
The FDA appointed Stanford physician-scientist and ex-biopharma executive George Tidmarsh as director of its largest division, the Center for Drug Evaluation and Research.
Features
-
Understanding the importance of randomized clinical trials
Randomized controlled trials are the gold standard for proving therapeutic value, drug safety and efficacy, shaping pricing, reimbursement and securing regulatory approval.
-
How oral GLP-1 drugs could disrupt the weight loss market
FDA-approved oral GLP-1 formulations for weight loss could disrupt the weight management market, outcompete injectables and reduce patient access barriers.
-
Understanding pharmaceutical patent thickets, exclusivity
Pharmaceutical companies increasingly rely on dense patent thickets, including continuation patents, to delay competition, extend exclusivity and protect profits.
-
How digital twins are reshaping clinical trials
As drug development costs soar and timelines tighten, AI digital twins help sponsors cut enrollment, speed timelines and improve trial design, while meeting regulatory standards.